LUMBY, British Columbia, Nov. 29 /PRNewswire-FirstCall/ -- avVaa World Health Care Products Inc. , a global biotechnology company offering therapeutic, natural skin and health care products, announced today that John (Jack) S. Farley is doing well and is in good spirits following a recent medical procedure. Mr. Farley is expected to make a full recovery over the next few weeks. Darrell Stevens, avVaa’s Marketing Consultant and Board Member and successful former pharmaceutical VP, has been appointed interim CEO.
Stevens, an industry executive of more than twenty-eight years, recently retired from AmerisourceBergen Drug Company, (formerly Bergen Brunswig Drug Company) a sixty billion dollar company. His management and operations expertise ranges from field sales to operations and procurement at AmerisourceBergen. After helping to launch Wow! Laboratories, which manufactured an over-the-counter plaque-fighting tablet, Stevens returned to AmerisourceBergen as Director of Strategic Accounts and eventually retired as Regional Vice President of Retail Sales.
avVaa World Health Care Products interim CEO Darrell Stevens said, “As CEO, Jack Farley has put together a dynamic infrastructure of both operations and sales professionals. avVaa’s Sales and Marketing team is currently negotiating a number of strategic agreements, both domestically and internationally, while building the company’s primary and secondary brands. Continued success with these directives and with other impending developments will help to propel avVaa to become a recognized leader in natural skin care products.”
Stevens continued, “As a dedicated board member, but also a firm believer in its skin and pet care products, I look forward to working closely with the avVaa team as we strive toward implementing these and other key initiatives. All of us here at avVaa wish Jack all of the very best in his recovery.”
About avVaa World Health Care Products
avVaa World Health Care Products is a global biotechnology company that specializes in effective, all natural, therapeutic skin care products that improve quality of life and well being for consumers. avVaa’s patented European skin care formulas are scientifically registered, FDA-Compliant, and were developed to relieve and treat the symptoms of common skin ailments, including: eczema, psoriasis and acne. avVaa is poised to manufacture and market its OTC NEUROSKIN line of skin care products through mass food and drug channels in the United States and globally.
The Company’s second generation of its unique, high-quality therapeutic skin care products includes a comprehensive line of Animal Care products designed to capture share of the $44 billion+ worldwide animal care and products market. avVaa sells its quality Animal Care products through partnerships with established distributors and retailers in both Canada and the United States.
For additional information visit: http://www.avvaa.com or http://www.otcfn.com/avvw.
Investor Relations: Merle Goertz (West Coast) of avVaa World Health Care Products, 1-604-688-2349; or Rick McCaffrey of OTC Financial Network, 1-781-444-6100 ext. 625, or visit: http://www.avvaa.com or http://www.otcfn.com/avvw.
Safe Harbor: Statements contained in this press release that are not based upon current or historical fact are forward looking in nature. Such forward- looking statements are subject to risks and uncertainties, which could cause actual results to differ materially from estimated results. Management cautions that all statements as to future results of operations are necessarily subject to risks, uncertainties, and events that may be beyond the control of AVVAA World Health Care Products, Inc. and no assurance can be given that such results will be achieved. Potential risks and uncertainties include but are not limited to the ability to procure, properly price, retain, and successfully complete projects, the availability of technical personnel, changes in technology, and competition.
avVaa World Health Care Products Inc.
CONTACT: Merle Goertz of avVaa, +1-604-688-2349; or Rick McCaffrey of OTCFinancial Network, +1-781-444-6100 ext. 625
